ARTICLE | Financial News
Merrimack aiming to raise $125M
July 11, 2013 12:02 AM UTC
Merrimack Pharmaceuticals Inc. (NASDAQ:MACK) proposed late Wednesday to raise $50 million through the sale of shares and $75 million through the sale of convertible senior notes due 2020. JPMorgan; BofA Merrill Lynch; Cowen; Oppenheimer; Guggenheim Securities; and Brean Capital are underwriters. Merrimack was off a penny to $6.99 on Wednesday. ...